Study finds people with SARS-CoV-2 antibodies may have low risk of future infection
Dealing with health insurance administrators costs billions in wasted time and lost productivity
24 February 2021Single-cell imaging to completely define tumor micro-metabolic state
24 February 2021Study finds people with SARS-CoV-2 antibodies may have low risk of future infection
People who have had evidence of a prior infection with SARS-CoV-2, the virus that causes COVID-19, appear to be well protected against being reinfected with the virus, at least for a few months, according to a newly published study from the National Cancer Institute (NCI). This finding may explain why reinfection appears to be relatively rare, and it could have important public health implications, including decisions about returning to physical workplaces, school attendance, the prioritization of vaccine distribution, and other activities.
